Theralase Technologies Inc. V.TLT

Next NR

[rhodiumd]

Next NR could very well be BTD approval... Tic toc...

[Eoganacht]

We should get the 3Q2024 financials and MD&A by the end of next week.

[DJDawg]

All the good discussion about the bladder study makes me want to iterate that TLT is not a one drug and one indication company. IV Ruvidar (Rutherrin) shows great promise for solid and liquid tumours Ruvidar has antiviral properties that are potent and only just starting to be understood Ruvidar may have a role in vaccine development (Manitoba work ongoing) Those multiple avenues are a nice way

[CancerSlayer]

In terms of de-risking, it's nice to also have the competition do some of the dirty work & lend us a hand by either underperforming &/or carrying excessive toxicity, all the while requiring an excessive number/duration of treatments.

[rhodiumd]

I understand what you're trying to say but I wouldn't go as far as calling it "nice". Let's all keep in mind that there are very real people going through hell involved in those other trials. It's sad to think some patients could have gotten a better treatment just because a referring doctor got a visit from a lobbyist linked to big pharma. Let's just be grateful for

[CancerSlayer]

..."paradoxically beneficial" would have been a better choice of words.  As this tech gains more attention/acceptance as dictated by the science/results, more sound decision-making can take place, which is the goal.

[Eoganacht]

I am very much looking forward to news from the CRA (Collaborative Research Agreement) with the National Microbiology Laboratory, Public Health Agency of Canada (“PHAC”) before the end of the year. According to the last MD&A: "Theralase® in conjunction with UM and PHAC have modified their focus to avian influenza (H5N1).   These results have now laid the groundwork

[Alamir1111]

Thank Eoganacht  hope we get some good news on virus front